Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Hassaan, M. Mohamed, E. Ramadan, M. Hashim, S. Sharaf (Riyadh, Saudi Arabia). LATE-BREAKING ABSTRACT: Procalcitonin as a diagnostic marker in acute exacerbation of COPD. Eur Respir J 2012; 40: Suppl. 56, 780

Member's Comments

No comment yet.

Related content which might interest you: Procalcitonin use in acute exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011 LATE-BREAKING ABSTRACT: CAT for evaluation of recovery after severe exacerbation of COPD Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 LATE-BREAKING ABSTRACT: The predictive value of the COPD assessment test (CAT) for acute exacerbations in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - New insights in pneumology - ERS inter-Assemblies late-breaking abstracts Year: 2012 LATE-BREAKING ABSTRACT: Biomarkres in exacerbations of chronic obstructive pulmonary disease (ECOPD) Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: Predictive factors of frequent exacerbations in mild grade COPD patients Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 LATE-BREAKING ABSTRACT: Validation of the DECAF score to predict hospital mortality in exacerbations of COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Copeptin – a marker for differential diagnosis between acute exacerbation of COPD and heart failure in patients with acute dyspnea Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Procalcitonin versus C-reactive protein in the management of severe acute exacerbations of COPD Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD Year: 2010 Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Pro-adrenomedullin and pro-endothelin-1 for assessment and prognosis of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 LATE-BREAKING ABSTRACT: The role of modification of CURB-65 score as prediction factor for one year survival in acute exacerbation of COPD Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 LATE-BREAKING ABSTRACT: A novel approach for identifying patients with undiagnosed clinically-significant COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 LATE-BREAKING ABSTRACT: Eosinophilic inflammation in COPD: During clinical stability and exacerbations. The AERIS study Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015